FDA Inspection 945583 — Mezzion Pharma Co., Ltd
The FDA completed an inspection of Mezzion Pharma Co., Ltd on Sep 11, 2015 in New Providence, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 11, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Providence, NJ (United States)
Additional details
Sponsor, Contract Research Organization